ALBERT BOURLA - 23 Feb 2024 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chairman & CEO, Director
Signature
Susan E. Grant, by power of atty., for Albert Bourla
Issuer symbol
PFE
Transactions as of
23 Feb 2024
Net transactions value
+$421,477
Form type
4
Filing time
27 Feb 2024, 13:46:16 UTC
Previous filing
16 Feb 2024
Next filing
28 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $3,490,607 +127,674 +41% $27.34 439,748 23 Feb 2024 Direct F1
transaction PFE Common Stock Tax liability $245,149 -8,831 -2% $27.76 430,917 23 Feb 2024 Direct F2
transaction PFE Common Stock Tax liability $2,823,982 -103,178 -24% $27.37 327,739 23 Feb 2024 Direct F3, F4
holding PFE Common Stock 4,750 23 Feb 2024 By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise $0 -127,674 -100% $0.000000* 0 23 Feb 2024 Common Stock 127,674 $27.34 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.